{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T18:32:52Z","timestamp":1780511572915,"version":"3.54.1"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010876","name":"Shanghai University of Traditional Chinese Medicine","doi-asserted-by":"publisher","award":["2021ZDCG05"],"award-info":[{"award-number":["2021ZDCG05"]}],"id":[{"id":"10.13039\/501100010876","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012543","name":"Shanghai Science and Technology Development Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011488","name":"Shanghai Pudong New Area Health Commission","doi-asserted-by":"publisher","award":["PWZxk2022-04"],"award-info":[{"award-number":["PWZxk2022-04"]}],"id":[{"id":"10.13039\/501100011488","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011488","name":"Shanghai Pudong New Area Health Commission","doi-asserted-by":"publisher","award":["PKJ2021-Y04"],"award-info":[{"award-number":["PKJ2021-Y04"]}],"id":[{"id":"10.13039\/501100011488","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ejpb.2025.114776","type":"journal-article","created":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T02:36:57Z","timestamp":1749263817000},"page":"114776","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Enhanced chemotherapy in thyroid carcinoma: A MnO2-silica nanoreactor activated by H2O2\/GSH for hypoxia relief"],"prefix":"10.1016","volume":"214","author":[{"given":"Menghan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongchao","family":"Mai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongna","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 2","key":"10.1016\/j.ejpb.2025.114776_b0005","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1038\/modpathol.2010.129","article-title":"Papillary thyroid carcinoma: an update","volume":"24","author":"LiVolsi","year":"2011","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.ejpb.2025.114776_b0010","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1507\/endocrj.EJ14-0303","article-title":"Static and dynamic prognostic factors of papillary thyroid carcinoma","volume":"61","author":"Ito","year":"2014","journal-title":"Endocr. J."},{"key":"10.1016\/j.ejpb.2025.114776_b0015","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s11864-006-0040-7","article-title":"Papillary thyroid cancer","volume":"7","author":"Caron","year":"2006","journal-title":"Curr. Treat. Options Oncol."},{"key":"10.1016\/j.ejpb.2025.114776_b0020","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/01.sla.0000250445.92336.2a","article-title":"Staging systems for papillary thyroid carcinoma: a review and comparison","volume":"245","author":"Lang","year":"2007","journal-title":"Ann. Surg."},{"key":"10.1016\/j.ejpb.2025.114776_b0025","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1016\/j.ymthe.2021.01.019","article-title":"METTL3 restrains papillary thyroid cancer progression via m(6)A\/c-Rel\/IL-8-mediated neutrophil infiltration","volume":"29","author":"He","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ejpb.2025.114776_b0030","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s11864-000-0048-3","article-title":"Papillary thyroid cancer","volume":"1","author":"Yim","year":"2000","journal-title":"Curr. Treat. Options Oncol."},{"key":"10.1016\/j.ejpb.2025.114776_b0035","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ijmedinf.2018.11.004","article-title":"Effects of chemotherapy prescription clinical decision-support systems on the chemotherapy process: a systematic review","volume":"122","author":"Rahimi","year":"2019","journal-title":"Int. J. Med. Inf."},{"key":"10.1016\/j.ejpb.2025.114776_b0040","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1056\/NEJM197602192940801","article-title":"Combination chemotherapy as an adjuvant treatment in operable breast cancer","volume":"294","author":"Bonadonna","year":"1976","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejpb.2025.114776_b0045","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23031532","article-title":"Pharmacological effects of cisplatin combination with natural products in cancer chemotherapy","volume":"23","author":"Dasari","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejpb.2025.114776_b0050","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.3389\/fphar.2019.01039","article-title":"Saikosaponin-d inhibits the hepatoma cells and enhances chemosensitivity through SENP5-dependent inhibition of Gli1 SUMOylation under hypoxia","volume":"10","author":"Zhang","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejpb.2025.114776_b0055","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.fct.2018.08.030","article-title":"Dauricine upregulates the chemosensitivity of hepatocellular carcinoma cells: role of repressing glycolysis via miR-199a:HK2\/PKM2 modulation","volume":"121","author":"Li","year":"2018","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.ejpb.2025.114776_b0060","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.phymed.2018.03.040","article-title":"Reversal effect of quercetin on multidrug resistance via FZD7\/beta-catenin pathway in hepatocellular carcinoma cells","volume":"43","author":"Chen","year":"2018","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ejpb.2025.114776_b0065","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.intimp.2012.06.010","article-title":"Saikosaponin a and its epimer saikosaponin d exhibit anti-inflammatory activity by suppressing activation of NF-kappaB signaling pathway","volume":"14","author":"Lu","year":"2012","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ejpb.2025.114776_b0070","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1142\/S0192415X14500797","article-title":"Saikosaponin-D attenuates heat stress-induced oxidative damage in LLC-PK1 cells by increasing the expression of anti-oxidant enzymes and HSP72","volume":"42","author":"Zhang","year":"2014","journal-title":"Am. J. Chin. Med."},{"key":"10.1016\/j.ejpb.2025.114776_b0075","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.bbrc.2016.05.017","article-title":"Saikosaponin-d: a potential chemotherapeutics in castration resistant prostate cancer by suppressing cancer metastases and cancer stem cell phenotypes","volume":"474","author":"Zhong","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejpb.2025.114776_b0080","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000356648","article-title":"Saikosaponin-D enhances radiosensitivity of hepatoma cells under hypoxic conditions by inhibiting hypoxia-inducible factor-1alpha","volume":"33","author":"Wang","year":"2014","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.ejpb.2025.114776_b0085","doi-asserted-by":"crossref","first-page":"4974","DOI":"10.1021\/acs.molpharmaceut.8b00595","article-title":"Synergetic and antagonistic Molecular effects mediated by the feedback loop of p53 and JNK between saikosaponin D and SP600125 on lung cancer A549 cells","volume":"15","author":"Chen","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2025.114776_b0090","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.3892\/etm.2014.1568","article-title":"Saikosaponin-d affects the differentiation, maturation and function of monocyte-derived dendritic cells","volume":"7","author":"Ying","year":"2014","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.ejpb.2025.114776_b0095","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.3892\/mmr.2017.6765","article-title":"Effects of saikosaponin D on apoptosis in human U87 glioblastoma cells","volume":"16","author":"Li","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.ejpb.2025.114776_b0100","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.jep.2015.12.058","article-title":"Anti-melanoma activity of Bupleurum chinense, Bupleurum kaoi and nanoparticle formulation of their major bioactive compound saikosaponin-d","volume":"179","author":"Hu","year":"2016","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ejpb.2025.114776_b0105","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.biopha.2018.09.038","article-title":"Saikosaponin D from radix bupleuri suppresses triple-negative breast cancer cell growth by targeting beta-catenin signaling","volume":"108","author":"Wang","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejpb.2025.114776_b0110","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.prp.2017.01.022","article-title":"Reversal of P-glycoprotein-mediated multidrug resistance is induced by saikosaponin D in breast cancer MCF-7\/adriamycin cells","volume":"213","author":"Li","year":"2017","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.ejpb.2025.114776_b0115","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.cbi.2013.08.006","article-title":"Saikosaponin D disrupts platelet-derived growth factor-beta receptor\/p38 pathway leading to mitochondrial apoptosis in human LO2 hepatocyte cells: a potential mechanism of hepatotoxicity","volume":"206","author":"Chen","year":"2013","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejpb.2025.114776_b0120","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.etap.2015.11.005","article-title":"Activation of fas death receptor pathway and bid in hepatocytes is involved in saikosaponin D induction of hepatotoxicity","volume":"41","author":"Zhang","year":"2016","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.ejpb.2025.114776_b0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drup.2016.03.001","article-title":"ABC transporters as mediators of drug resistance and contributors to cancer cell biology","volume":"26","author":"Fletcher","year":"2016","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.ejpb.2025.114776_b0130","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.drup.2011.03.001","article-title":"Hypoxia-mediated drug resistance: novel insights on the functional interaction of HIFs and cell death pathways","volume":"14","author":"Rohwer","year":"2011","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.ejpb.2025.114776_b0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012038","article-title":"Hypoxia-inducible factor 1alpha determines gastric cancer chemosensitivity via modulation of p53 and NF-kappaB","volume":"5","author":"Rohwer","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.ejpb.2025.114776_b0140","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrc706","article-title":"Multidrug resistance in cancer: role of ATP-dependent transporters","volume":"2","author":"Gottesman","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejpb.2025.114776_b0145","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1089\/ars.2013.5378","article-title":"The clinical importance of assessing tumor hypoxia: relationship of tumor hypoxia to prognosis and therapeutic opportunities","volume":"21","author":"Walsh","year":"2014","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.ejpb.2025.114776_b0150","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1093\/jnci\/93.4.266","article-title":"Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects","volume":"93","author":"Hockel","year":"2001","journal-title":"J. Natl Cancer Inst."},{"issue":"Suppl 5","key":"10.1016\/j.ejpb.2025.114776_b0155","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1634\/theoncologist.9-90005-10","article-title":"The role of hypoxia-induced factors in tumor progression","volume":"9","author":"Vaupel","year":"2004","journal-title":"Oncologist"},{"key":"10.1016\/j.ejpb.2025.114776_b0160","doi-asserted-by":"crossref","first-page":"39762","DOI":"10.1038\/srep39762","article-title":"Pulsation-limited oxygen diffusion in the tumour microenvironment","volume":"7","author":"Milotti","year":"2017","journal-title":"Sci. Rep."},{"issue":"Suppl 5","key":"10.1016\/j.ejpb.2025.114776_b0165","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1634\/theoncologist.9-90005-4","article-title":"Tumor hypoxia: causative factors, compensatory mechanisms, and cellular response","volume":"9","author":"Vaupel","year":"2004","journal-title":"Oncologist"},{"key":"10.1016\/j.ejpb.2025.114776_b0170","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/nbt1109","article-title":"Engineering vascularized skeletal muscle tissue","volume":"23","author":"Levenberg","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ejpb.2025.114776_b0175","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1053\/j.semnuclmed.2014.10.002","article-title":"Biology of hypoxia","volume":"45","author":"Span","year":"2015","journal-title":"Semin. Nucl. Med."},{"key":"10.1016\/j.ejpb.2025.114776_b0180","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.biomaterials.2017.02.017","article-title":"Orthogonal near-infrared upconversion co-regulated site-specific O2 delivery and photodynamic therapy for hypoxia tumor by using red blood cell microcarriers","volume":"125","author":"Wang","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejpb.2025.114776_b0185","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.actbio.2017.06.035","article-title":"Oxygen self-enriched nanoparticles functionalized with erythrocyte membranes for long circulation and enhanced phototherapy","volume":"59","author":"Ren","year":"2017","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ejpb.2025.114776_b0190","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.biomaterials.2018.06.007","article-title":"Biomimetic O2-evolving metal-organic framework nanoplatform for highly efficient photodynamic therapy against hypoxic tumor","volume":"178","author":"Gao","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejpb.2025.114776_b0195","first-page":"1702101","article-title":"Light\u2010Triggered clustered vesicles with self\u2010supplied oxygen and tissue penetrability for photodynamic therapy against hypoxic","volume":"27","author":"Li","year":"2017","journal-title":"Tumor"},{"key":"10.1016\/j.ejpb.2025.114776_b0200","doi-asserted-by":"crossref","first-page":"6060","DOI":"10.1039\/c3cs35486e","article-title":"Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes","volume":"42","author":"Wei","year":"2013","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ejpb.2025.114776_b0205","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1021\/nn405773r","article-title":"Multifunctional albumin-MnO(2) nanoparticles modulate solid tumor microenvironment by attenuating hypoxia, acidosis, vascular endothelial growth factor and enhance radiation response","volume":"8","author":"Prasad","year":"2014","journal-title":"ACS Nano"},{"key":"10.1016\/j.ejpb.2025.114776_b0210","unstructured":"H. Wei, X. Wang, Y.J.I.C.F. Hu, Nanozymes in bionanotechnology: from sensing to therapeutics and beyond, (2016)."},{"key":"10.1016\/j.ejpb.2025.114776_b0215","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.tibtech.2017.09.006","article-title":"Emerging biomedical applications of enzyme-like catalytic nanomaterials","volume":"36","author":"Cormode","year":"2018","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.ejpb.2025.114776_b0220","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.mattod.2024.01.011","article-title":"Dual-targeting nanozyme combined with aPD-L1-based immunotherapy for combating cancer recurrence and metastasis","volume":"73","author":"Tang","year":"2024","journal-title":"Mater. Today"},{"key":"10.1016\/j.ejpb.2025.114776_b0225","article-title":"\u201cAll-in-one\u201d MnO2@PtAuRu nanoreactor for self-replenishing and cascade catalytic therapy of cancer","volume":"20","author":"Li","year":"2024","journal-title":"Small"},{"key":"10.1016\/j.ejpb.2025.114776_b0230","doi-asserted-by":"crossref","first-page":"12295","DOI":"10.1021\/acsnano.4c01229","article-title":"Genetically edited cascade nanozymes for cancer immunotherapy","volume":"18","author":"Zhang","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.ejpb.2025.114776_b0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122574","article-title":"A ferroptosis amplifier based on triple-enhanced lipid peroxides accumulation strategy for effective pancreatic cancer therapy","volume":"309","author":"Chen","year":"2024","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejpb.2025.114776_b0240","doi-asserted-by":"crossref","first-page":"11764","DOI":"10.1002\/anie.201807595","article-title":"Hybrid nanoreactors: enabling an off-the-shelf strategy for concurrently enhanced chemo-immunotherapy","volume":"57","author":"Yang","year":"2018","journal-title":"Angew. Chemie (Int. Ed. English)"},{"key":"10.1016\/j.ejpb.2025.114776_b0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121636","article-title":"Tumor-microenvironment triggered signal-to-noise boosting nanoprobes for NIR-IIb fluorescence imaging guided tumor surgery and NIR-II photothermal therapy","volume":"287","author":"Wang","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejpb.2025.114776_b0250","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201704833","article-title":"Near-Infrared upconversion mesoporous cerium oxide hollow biophotocatalyst for concurrent pH-\/H2O2 -responsive O2 -evolving synergetic cancer therapy","volume":"30","author":"Yao","year":"2018","journal-title":"Adv. Mater. (Deerfield Beach Fla.)"},{"key":"10.1016\/j.ejpb.2025.114776_b0255","article-title":"Biodegradable nanoprobe for NIR-II fluorescence image-guided surgery and enhanced breast cancer radiotherapy efficacy","volume":"9","author":"Yang","year":"2022","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.ejpb.2025.114776_b0260","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.jcis.2022.06.069","article-title":"Folic acid conjugated PAMAM-modified mesoporous silica-coated superparamagnetic iron oxide nanoparticles for potential cancer therapy","volume":"625","author":"Sagir","year":"2022","journal-title":"J. Colloid Interf. Sci."},{"key":"10.1016\/j.ejpb.2025.114776_b0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2021.214309","article-title":"Chemically engineered mesoporous silica nanoparticles-based intelligent delivery systems for theranostic applications in multiple cancerous\/non-cancerous diseases","volume":"452","author":"Zhou","year":"2022","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.ejpb.2025.114776_b0270","doi-asserted-by":"crossref","first-page":"5365","DOI":"10.1039\/D1CS00659B","article-title":"Engineering mesoporous silica nanoparticles for drug delivery: where are we after two decades?","volume":"51","author":"Vallet-Reg\u00ed","year":"2022","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ejpb.2025.114776_b0275","article-title":"Tumor microenvironment-responsive delivery nanosystems reverse immunosuppression for enhanced CO gas\/immunotherapy","volume":"3","author":"Chen","year":"2023","journal-title":"Exploration (Beijing, China)"},{"key":"10.1016\/j.ejpb.2025.114776_b0280","article-title":"Camouflaged virus-like-nanocarrier with a transformable rough surface for boosting drug delivery","volume":"62","author":"Yu","year":"2023","journal-title":"Angew. Chemie (Int. Ed. English)"},{"key":"10.1016\/j.ejpb.2025.114776_b0285","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1021\/nn405773r","article-title":"Multifunctional albumin-MnO2 nanoparticles modulate solid tumor microenvironment by attenuating hypoxia, acidosis, vascular endothelial growth factor and enhance radiation response","volume":"8","author":"Prasad","year":"2014","journal-title":"ACS Nano"},{"key":"10.1016\/j.ejpb.2025.114776_b0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110579","article-title":"Saikosaponin d modulates the polarization of tumor-associated macrophages by deactivating the PI3K\/AKT\/mTOR pathway in murine models of pancreatic cancer","volume":"122","author":"Xu","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ejpb.2025.114776_b0295","article-title":"Saikosaponin D suppresses esophageal squamous cell carcinoma via the PI3K-AKT signaling pathway","author":"Duan","year":"2024","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.ejpb.2025.114776_b0300","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s12640-021-00438-7","article-title":"Saikosaponin-D mitigates oxidation in SH-SY5Y cells stimulated by Glutamate through activation of Nrf2 pathway: involvement of PI3K","volume":"40","author":"Du","year":"2022","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.ejpb.2025.114776_b0305","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/s41392-021-00828-5","article-title":"Targeting PI3K\/Akt signal transduction for cancer therapy","volume":"6","author":"He","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ejpb.2025.114776_b0310","doi-asserted-by":"crossref","unstructured":"J.F. Hechtman, NTRK insights: best practices for pathologists, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 35 (2022) 298-305.","DOI":"10.1038\/s41379-021-00913-8"}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641125001535?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641125001535?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T15:10:41Z","timestamp":1753974641000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641125001535"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":62,"alternative-id":["S0939641125001535"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2025.114776","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhanced chemotherapy in thyroid carcinoma: A MnO2-silica nanoreactor activated by H2O2\/GSH for hypoxia relief","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2025.114776","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114776"}}